Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut. The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with type 2 diabetes and non-diabetic persons as control. METHODS AND FINDINGS: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time quantitative PCR (qPCR) and in a subgroup of subjects (N = 20) by tag-encoded amplicon pyrosequencing of the V4 region of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic group compared to the control group (P = 0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose concentration (P = 0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to non-diabetic persons (P = 0.02) and positively correlated with plasma glucose (P = 0.04). CONCLUSIONS: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compelling evidence have shown that the composition of the gut microbiota is altered in animal models of obesity and subjects with prediabetes or type 2 diabetes compared with controls (182–186).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [183]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Chronic autoimmune inflammatory diseases, including celiac disease,17 type 2 diabetes18 and obesity19 are associated with intestinal dysbiosis.”
From Probiotics and the gut microbiota in intestinal health and disease (2010) · cites this paper as [18]
In the citing paper
“Conversely, heterocyclic amines and glycan derived from red meat may promote inflammation in gut health due to higher concentration of Bacteroides and Fusobacterium and lower levels of Lactobacillus and Roseburia, which are also linked with lower anti-inflammatory responses and increased incidence of type 2 diabetes [191,192,193].”
From Impact of Protein Intake in Older Adults with Sarcopenia and Obesity: A Gut Microbiota Perspective (2020) · cites this paper as [191]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
[RETRACTION]Translational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M., Carvalho, B. M., Carvalho-Filho, M. A., & Saad, M. J. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000200004 · Cited by 44
RetractedTranslational research into gut microbiota: new horizons in obesity treatment
Tsukumo, D. M. L., Carvalho, B. M., Filho, C., & Saad, M. J. A. (2013) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302013000900014 · Cited by 17
RetractedAn obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 1×
“The differences in microbial composition were explained by an increased capacity of the obesity-associated microbiome to harvest energy from the diet [13].”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Naslain, D., Neyrinck, A., Lambert, D. M., et al. (2009) · Gut · doi:10.1136/gut.2008.165886 · Cited by 2,518 · cited 2×
“For example, levels of Bifidobacterium significantly and positively correlated with improved glucose-tolerance and low-grade inflammation in prebiotic treated-mice [1,6].”
BackgroundMicrobiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457
Cited by
Items 501–600 of 1,020
Sun, J., & Buys, N. J. (2016) · British Journal of Nutrition · doi:10.1017/s0007114516000076 · Cited by 122
“One of the possible mechanisms by which this effect occurs is through the impact of probiotics on changing intestinal microbiota((4,29)).”
BackgroundThe effect of gut microbiota on drug metabolism
Kang, M. J., Kim, H. G., Kim, J. S., Oh, D. G., Um, Y. J., Seo, C. S., Han, J. W., Cho, H. J., Kim, G. H., Jeong, T. C., et al. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.807798 · Cited by 120
“Three factors should be taken into consideration when examining xenobiotic metabolism by the intestinal microbiota [6,7].”
BackgroundThe struggle within: Microbial influences on colorectal cancer
Arthur, J. C., & Jobin, C. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21354 · Cited by 122
Lee, S.-M., Han, H. W., & Yim, S. Y. (2015) · Food & Function · doi:10.1039/c4fo00731j · Cited by 122
Dietary Flavonoids in the Prevention of T2D: An Overview
Alkhalidy, H., Wang, Y., & Liu, D. (2018) · Nutrients · doi:10.3390/nu10040438 · Cited by 143
Giuffrè, M., Campigotto, M., Campisciano, G., Comar, M., & Crocè, L. S. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00161.2019 · Cited by 128
Edible fungal polysaccharides, the gut microbiota, and host health
Liang, J., Zhang, M., Wang, X., Ren, Y., Yue, T., Wang, Z., & Gao, Z. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118558 · Cited by 128
Gut Microbiota and the Pathogenesis of Insulin Resistance
Delzenne, N. M., & Cani, P. D. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0191-1 · Cited by 134
Tajabadi-Ebrahimi, M., Sharifi, N., Farrokhian, A., Raygan, F., Karamali, F., Razzaghi, R., Taheri, S., & Asemi, Z. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0042-105441 · Cited by 114
Nishitsuji, K., Xiao, J., Nagatomo, R., Umemoto, H., Morimoto, Y., Akatsu, H., Inoue, K., & Tsuneyama, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-16189-5 · Cited by 118
Masse, K. E., & Lu, V. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1169624 · Cited by 120
Metabolomics – the complementary field in systems biology: a review on obesity and type 2 diabetes
Bakar, M. H. A., Sarmidi, M. R., Cheng, K., Khan, A. A., Suan, C. L., Huri, H. Z., & Yaakob, H. (2015) · Molecular BioSystems · doi:10.1039/c5mb00158g · Cited by 129
Yamaguchi, Y., Adachi, K., Sugiyama, T., Shimozato, A., Ebi, M., Ogasawara, N., Funaki, Y., Goto, C., Sasaki, M., & Kasugai, K. (2016) · Digestion · doi:10.1159/000447690 · Cited by 118
Microbiota in obesity: interactions with enteroendocrine, immune and central nervous systems
Mulders, R. J., de Git, K. C. G., Schéle, E., Dickson, S. L., Sanz, Y., & Adan, R. A. H. (2018) · Obesity Reviews · doi:10.1111/obr.12661 · Cited by 120
Gut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain Axis
Bullich, C., Keshavarzian, A., Garssen, J., Kraneveld, A., & Perez‐Pardo, P. (2019) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12840 · Cited by 114
Liu, H.-X., Rocha, C. S., Dandekar, S., & Yvonne Wan, Y.-J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.09.022 · Cited by 117
“Alterations in gut bacterial communities are associated with metabolic disorders [8], metabolic syndrome [9], obesity [10–12], and non-alcoholic steatohepatitis [13].”
BackgroundJi, Y., Kim, H., Park, H., Lee, J., Yeo, S., Yang, J., Park, S., Yoon, H., Cho, G., Franz, C., et al. (2012) · Beneficial Microbes · doi:10.3920/bm2011.0046 · Cited by 117
Gao, K., Yang, R., Zhang, J., Wang, Z., Jia, C., Zhang, F., Li, S., Wang, J., Murtaza, G., Xie, H., et al. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.011 · Cited by 128
“eobacteria than that of healthy individuals [7].”
Respondek, F., Gerard, P., Bossis, M., Boschat, L., Bruneau, A., Rabot, S., Wagner, A., & Martin, J.-C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071026 · Cited by 116
Bile acid dysregulation, gut dysbiosis, and gastrointestinal cancer
Tsuei, J., Chau, T., Mills, D., & Wan, Y.-J. Y. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214538743 · Cited by 116
“Metagenome sequencing of the fecal microbiome of obese individuals was consistent with these murine study findings.(94,95) Weight loss studies further showed that a decrease in firmicutes and an increase of bacteroides were correlated with percent body weight loss, but not caloric intake.”
ResultTowards Predictive Models of the Human Gut Microbiome
Bucci, V., & Xavier, J. B. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.03.017 · Cited by 113
“017 as obesity [43], diabetes [44] and Crohn's disease [45].”
BackgroundYang, J., Dong, H., Wang, Y., Jiang, Y., Zhang, W., Lu, Y., Chen, Y., & Chen, L. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.06.153 · Cited by 129
Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus
Du, L., Li, Q., Yi, H., Kuang, T., Tang, Y. P., & Fan, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112839 · Cited by 131
Bacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology
Mills, S., Ross, R. P., & Hill, C. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux022 · Cited by 128
“Patients with type 2 diabetes exhibited an increased abundance of the Betaproteobacteria class, a higher Bacteroidetes/Firmicutes ratio and lower levels of Clostridia when compared to healthy individuals (Larsen et al. 2010).”
BackgroundLyu, Y., Wu, L., Wang, F., Shen, X., & Lin, D. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218763760 · Cited by 124
Li, B., Xu, X., Gan, R., Sun, Q., Meng, J.-M., Shang, A., Mao, Q., & Li, H. (2019) · Foods · doi:10.3390/foods8100440 · Cited by 123
“Case-control study Adults with T2DM (n = 18) Healthy male adults (n = 18) ↓ The proportions of phylum Firmicutes and class Clostridia, and the ratios of Firmicutes to Bacteroidetes ↑ The proportion of betaproteobacteria [101]”
Background“Omics” in pharmaceutical research: overview, applications, challenges, and future perspectives
Yan, S., Liu, R., Jin, H., Liu, X., Ye, J., Shan, L., & Zhang, W. (2015) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(15)60002-4 · Cited by 130
“Metagenomics studies have also demonstrated an imbalanced microbiota composition in various diseases, such as Crohn's disease ([13]), necrotizing enterocolitis ([14]), polyposis or colorectal cancer ([15]), and type 2 diabetes ([16]).”
BackgroundMicrobiota associated with type 2 diabetes and its related complications
Zhang, Y., & Zhang, H. (2013) · Food Science and Human Wellness · doi:10.1016/j.fshw.2013.09.002 · Cited by 130
Ejtahed, H., Soroush, A. R., Angoorani, P., Larijani, B. A., & Hasani‐Ranjbar, S. (2016) · Hormone and Metabolic Research · doi:10.1055/s-0042-107792 · Cited by 120
Tryptophan Predicts the Risk for Future Type 2 Diabetes
Chen, T., Zheng, X., Ma, X., Bao, Y., Ni, Y., Hu, C., Rajani, C., Huang, F., Zhao, A., Jia, W., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0162192 · Cited by 113
“In this report, baseline tryptophan level was different in future T2D and future NGT (Fig 1a and Table 1), supporting previous metagenomic findings that patients with impaired glucose metabolism, insulin resistance, or T2D were featured by imbalanced microbiota, such as less butyrate-producing bacteria (Roseburia spec…”
ResultHou, Q., Kwok, L. Y., Zheng, Y., Wang, L., Guo, Z., Zhang, J., Huang, W., Wang, Y., Leng, L., Li, H., et al. (2016) · Scientific Reports · doi:10.1038/srep37376 · Cited by 125
Akbari, V., & Hendijani, F. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw039 · Cited by 109
Remodeling of the gut microbiota and structural shifts in Preeclampsia patients in South China
Liu, J., Yang, H., Yin, Z., Jiang, X., Zhong, H., Qiu, D., Zhu, F., & Li, R. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2853-z · Cited by 121
Feruloylated oligosaccharides and ferulic acid alter gut microbiome to alleviate diabetic syndrome
Song, Y., Wu, M.-S., Tao, G., Lu, M., Lin, J., & Huang, J. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109410 · Cited by 119
Chen, X., Wu, J., Fu, X., Wang, P., & Chen, C. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126038 · Cited by 118
Ma, X., Asif, H., Dai, L., He, Y., Zheng, W., Wang, D., Ren, H., Tang, J., Li, C., Jin, K., et al. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.02.005 · Cited by 114
Suryavanshi, M. V., Bhute, S. S., Jadhav, S. D., Bhatia, M. S., Gune, R. P., & Shouche, Y. S. (2016) · Scientific Reports · doi:10.1038/srep34712 · Cited by 117
Rodríguez-Carrio, J., López, P., Sánchez, B., González, S., Gueimonde, M., Margolles, A., de los Reyes-Gavilán, C. G., & Suárez, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00023 · Cited by 113
Al-Assal, K., Martinez, A. C., Torrinhas, R. S., Cardinelli, C., & Waitzberg, D. (2018) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2018.03.001 · Cited by 112
Li, X., Chen, H., He, Y., Chen, W., Chen, J., Gao, L., Hu, H., & Wang, J. (2018) · Molecules · doi:10.3390/molecules23123245 · Cited by 121
“It was reported that the intestinal flora of diabetic patients are significant difference from non-diabetic adults [40]; it has been verified that the Bacteroidetes to Firmicutes ratio was decreased in T2DM individuals [41].”
BackgroundRole of dietary edible mushrooms in the modulation of gut microbiota
Li, M., Yu, L., Zhao, J., Zhang, H., Chen, W., Zhai, Q., & Tian, F. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104538 · Cited by 121
Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders
Sankararaman, S., Noriega, K. J., Velayuthan, S., Sferra, T. J., & Martindale, R. G. (2022) · Current Gastroenterology Reports · doi:10.1007/s11894-022-00859-0 · Cited by 121
Epidemiology and clinical pathophysiology of uric acid kidney stones
Sakhaee, K. (2014) · Journal of Nephrology · doi:10.1007/s40620-013-0034-z · Cited by 137
Lê, K., Li, Y., Xu, X., Yang, W., Liu, T., Zhao, X., Tang, Y. G., Cai, D., Go, V. L. W., Pandol, S., et al. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2012.00496 · Cited by 131
“Previous studies have shown that specific gut microbiota composition is linked to the presence of T2D (Larsen et al., 2010; Wu et al., 2010b).”
BackgroundResultSpatial and Temporal Features of the Growth of a Bacterial Species Colonizing the Zebrafish Gut
Jemielita, M., Taormina, M. J., Burns, A. R., Hampton, J. S., Rolig, A. S., Guillemin, K. J., & Parthasarathy, R. (2014) · mBio · doi:10.1128/mbio.01751-14 · Cited by 137
Prattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 122
The Gut–Eye Axis: Lessons Learned from Murine Models
Floyd, J. L., & Grant, M. B. (2020) · Ophthalmology and Therapy · doi:10.1007/s40123-020-00278-2 · Cited by 125
Ozaki, D., Kubota, R., Maeno, T., Abdelhakim, M., & Hitosugi, N. (2020) · Osteoporosis International · doi:10.1007/s00198-020-05728-y · Cited by 127
Prokopidis, K., Chambers, E., Ni Lochlainn, M., & Witard, O. C. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.770455 · Cited by 102
Rajilić-Stojanović, M. D. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.006 · Cited by 130
Masanta, W. O., Heimesaat, M. M., Bereswill, S., Tareen, A. M., Lugert, R., Groß, U., & Zautner, A. E. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/526860 · Cited by 123
“1 diabetes [43], type 2 diabetes [44], obesity [45], inflammatory bowel disease (including Crohn’s disease and ulcerative colitis) [46], irritable bowel syndrome [47], and celiac disease [48], among others, have been shown to be associated with shifted microbiota composition.”
BackgroundGut commensals and their metabolites in health and disease
Krishnamurthy, H. K., Pereira, M., Bosco, J., George, J., Jayaraman, V., Krishna, K., Wang, T., Bei, K., & Rajasekaran, J. J. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1244293 · Cited by 125
Role of dietary beta-glucans in the prevention of the metabolic syndrome
Cloetens, L., Ulmius, M., Johansson-Persson, A., Åkesson, B., & Önning, G. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2012.00494.x · Cited by 108
Shobar, R., Velineni, S., Keshavarzian, A., Swanson, G. R., DeMeo, M. T., Melson, J. E., Losurdo, J., Engen, P. A., Sun, Y., Koenig, L., et al. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.54 · Cited by 119
Eid, H. M., Wright, M. L., Anil Kumar, N. V., Qawasmeh, A., Hassan, S. T. S., Mocan, A., Nabavi, S. M., Rastrelli, L., Atanasov, A. G., & Haddad, P. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00387 · Cited by 103
“Differences in the composition of the gut microbiota in humans that relate to disease have been reported for several conditions including, but not limited to, cardiovascular disease (Holmes et al., 2008; Wang et al., 2011), type 2 diabetes (Larsen et al., 2010), and obesity (Turnbaugh et al., 2009).”
BackgroundXin, Y., Diling, C., Jian, Y., Ting, L., Guoyan, H., Hualun, L., Xiaocui, T., Guoxiao, L., Ou, S., Chaoqun, Z., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00412 · Cited by 104
Microbiota-accessible pectic poly- and oligosaccharides in gut health
Tingirikari, J. M. R. (2018) · Food & Function · doi:10.1039/c8fo01296b · Cited by 114
Gut Microbiota Has a Widespread and Modifiable Effect on Host Gene Regulation
Richards, A. L., Muehlbauer, A. L., Alazizi, A., Burns, M. B., Findley, A. S., Messina, F., Gould, T. J., Cascardo, C. A., Piqué-Regi, R., Blekhman, R., et al. (2019) · mSystems · doi:10.1128/msystems.00323-18 · Cited by 130
“The gut microbiota has a variety of functions within the host, such as metabolism of certain compounds [1, 18, 21, 46], and its composition is correlated with several diseases, such as Crohn’s disease and colorectal cancer [7, 19, 29, 41, 47, 50].”
Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease
Naseer, M., Bibi, F., Alqahtani, M., Chaudhary, A., Azhar, E., Kamal, M., & Yasir, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660147 · Cited by 109
“The significant reduction in phylum Firmicutes and class Clostridia was observed in the diabetic group compared to the control subjects [10].”
BackgroundImpact of diet and the bacterial microbiome on the mucous barrier and immune disorders
Alemao, C. A., Budden, K. F., Gomez, H. M., Rehman, S. F., Marshall, J. E., Shukla, S. D., Donovan, C., Forster, S. C., Yang, I. A., Keely, S., et al. (2020) · Allergy · doi:10.1111/all.14548 · Cited by 117
Diet and host–microbial crosstalk in postnatal intestinal immune homeostasis
Jain, N., & Walker, W. A. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.153 · Cited by 102
Li, C., Li, X., Han, H., Cui, H., Peng, M., Wang, G., & Wang, Z. (2016) · Medicine · doi:10.1097/md.0000000000004088 · Cited by 108
Zhao, F., Liu, Q., Cao, J., Xu, Y., Pei, Z., Fan, H., Yuan, Y., Shen, X., & Li, C. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.110886 · Cited by 111
Ardeshirlarijani, E., Tabatabaei‐Malazy, O., Mohseni, S., Qorbani, M., Larijani, B. A., & Jalili, R. B. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00302-2 · Cited by 119
The Play of Genes and Non-genetic Factors on Type 2 Diabetes
Mambiya, M., Shang, M., Wang, Y., Li, Q., Liu, S., Yang, L., Zhang, Q., Zhang, K., Liu, M., Nie, F., et al. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00349 · Cited by 121
“Results in a number of recent studies have suggest that gut microbiota in individuals with Type 2 diabetes differs from that of non-diabetic individuals (62), such that there is a co relationship that exists between Type 2 diabetes and increased abundance of Lactobacillus, lowered abundance of butyrate-producing micro…”
ResultNegatu, D. A., Gengenbacher, M., Dartois, V. A., & Dick, T. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575586 · Cited by 119
Vigsnæs, L. K., Brynskov, J., Steenholdt, C., Wilcks, A., & Licht, T. R. (2012) · Beneficial Microbes · doi:10.3920/bm2012.0018 · Cited by 107
King, G. M. (2014) · The Journal of Microbiology · doi:10.1007/s12275-014-4364-x · Cited by 109
“Many additional studies have established strong linkages between microbiome composition and activity, and a variety of diseases (Armougom et al., 2009; Larsen et al., 2010; Hu et al., 2011).”
BackgroundOlvera-Rosales, L.-B., Cruz-Guerrero, A.-E., Ramírez-Moreno, E., Quintero-Lira, A., Contreras-López, E., Jaimez-Ordaz, J., Castañeda-Ovando, A., Añorve-Morga, J., Calderón-Ramos, Z.-G., Arias-Rico, J., et al. (2021) · Foods · doi:10.3390/foods10061261 · Cited by 94
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties
Pellegrino, A., Coppola, G., Santopaolo, F., Gasbarrini, A., & Ponziani, F. R. (2023) · Nutrients · doi:10.3390/nu15081815 · Cited by 112
A systematic review on gut microbiota in type 2 diabetes mellitus
Chong, S., Lin, M., Chong, D., Jensen, S. O., & Lau, N. S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1486793 · Cited by 127
Yoshifuji, A., Wakino, S., Irie, J., Tajima, T., Hasegawa, K., Kanda, T., Tokuyama, H., Hayashi, K., & Itoh, H. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv353 · Cited by 115
Ripened Pu-erh Tea Extract Protects Mice from Obesity by Modulating Gut Microbiota Composition
Lu, X., Liu, J., Zhang, N., Fu, Y., Zhang, Z., Li, Y., Wang, W., Li, Y., Shen, P. F., & Cao, Y. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b04909 · Cited by 110
Human intervertebral discs harbour a unique microbiome and dysbiosis determines health and disease
Rajasekaran, S., Soundararajan, D. C. R., Tangavel, C., Raveendran, M., Anand, K. S. S. V., Matchado, M. S., Nayagam, S. M., Shetty, A. P., Kanna, R. M., & Dharmalingam, K. (2020) · European Spine Journal · doi:10.1007/s00586-020-06446-z · Cited by 119
Capsaicin and Gut Microbiota in Health and Disease
Roşca, A. E., Ieșanu, M. I., Zahiu, C. D. M., Voiculescu, S. E., Paslaru, A. C., & Zăgrean, A. (2020) · Molecules · doi:10.3390/molecules25235681 · Cited by 116
Control of antiviral immunity by pattern recognition and the microbiome
Pang, I. K., & Iwasaki, A. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01073.x · Cited by 102
“Aberrant changes in the intestinal microbiome as a result of host genetics or antibiotic therapy in humans are associated with an increasing number of pathological conditions including obesity (76), inflammatory bowel disease (77), diabetes (78), and atopic diseases (79).”
BackgroundLoss of NHE3 alters gut microbiota composition and influences Bacteroides thetaiotaomicron growth
Engevik, M. A., Aihara, E., Montrose, M. H., Shull, G. E., Hassett, D. J., & Worrell, R. T. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00184.2013 · Cited by 105
“3 Introduction: 48 The alteration of normal gut microbiota is known to play a role in a variety of complex diseases such as 49 obesity (85), (51), (52), (86), (2), (84), (3), diabetes (9), (47), Inflammatory Bowel Disease (28), (30), (68), 50 (56), (70), Antibiotic-associated diarrhea (92) and Clostridium difficile-as…”
BackgroundGut microbiome and liver disease
Betrapally, N. S., Gillevet, P. M., & Bajaj, J. S. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.005 · Cited by 103
“This dy biosis can lead to obesity (25) (26) , metabolic syndromes (27) , diabetes (28) (29), card iovascular diseases (30), Nonalcoholic Fatty Liver Disease (NAFLD) (31), Nonalcoholic steatohep atitis (NASH) (32) Alcoholic Liver Diseases (33).”
BackgroundThe central role of the gut microbiota in the pathophysiology and management of type 2 diabetes
Baars, D. P., Fondevila, M. F., Meijnikman, A. S., & Nieuwdorp, M. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.07.017 · Cited by 121
Och, A., Och, M., Nowak, R., Podgórska, D., & Podgórski, R. (2022) · Molecules · doi:10.3390/molecules27041351 · Cited by 104
Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus
Sohail, M. U., Althani, A., Anwar, H., Rizzi, R., & Marei, H. E. (2017) · Journal of Diabetes Research · doi:10.1155/2017/9631435 · Cited by 99
Zheng, W., Xu, Q., Huang, W., Yan, Q. J., Chen, Y., Zhang, L., Tian, Z., Liu, T., Yuan, X., Liu, C., et al. (2020) · mSystems · doi:10.1128/msystems.00109-20 · Cited by 112
“The denominator taxa of Bacteroides identified by balance tree analysis, which were more abundant in GDM women in both T1 and T2, have been associated with serum proinflammatory interferon gamma levels (37), insulin resistance (38), and plasma glucose levels (39).”
BackgroundEnterotype Bacteroides Is Associated with a High Risk in Patients with Diabetes: A Pilot Study
Wang, J., Li, W., Wang, C., Wang, L., He, T., Hu, H., Song, J., Cui, C., Qiao, J., Qing, L., et al. (2020) · Journal of Diabetes Research · doi:10.1155/2020/6047145 · Cited by 103
“Diversity analysis showed that the composition of the microbiota was different between the control and T2D group, and the T2D group had lower bacterial diversity than the control group, findings that are consistent with former studies [1, 2].”
BackgroundResultInfluentialMadempudi, R. S., Ahire, J. J., Neelamraju, J., Tripathi, A., & Nanal, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225168 · Cited by 110
“Significantly lower relative abundance of Firmicutes and higher proportions of Bacteroidetes and Proteobacteria are found in T2DM persons compared to non-diabetic counterparts [6].”
BackgroundHippe, B., Zwielehner, J., Liszt, K., Lassl, C., Unger, F., & Haslberger, A. G. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2010.02197.x · Cited by 99
Bergström, A., Licht, T. R., Wilcks, A., Andersen, J. B., Schmidt, L. R., Grønlund, H. A., Vigsnaes, L. K., Michaelsen, K. F., & Bahl, M. I. (2012) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12004 · Cited by 98
“Real-time qPCR analysis has these properties and is a relatively simple and affordable technique, which offers a high degree of reproducibility and specificity and has thus found extensive use in the quantitative analysis of gut bacterial populations (Huijsdens et al., 2002; Bartosch et al., 2004; Gueimonde et al., 20…”
BackgroundMethodMarques, T. M., Wall, R., O'Sullivan, O., Fitzgerald, G. F., Shanahan, F., Quigley, E. M., Cotter, P. D., Cryan, J. F., Dinan, T. G., Ross, R. P., et al. (2015) · British Journal of Nutrition · doi:10.1017/s0007114514004206 · Cited by 102
Diabetes Mellitus and Increased Tuberculosis Susceptibility: The Role of Short-Chain Fatty Acids
Lachmandas, E., van den Heuvel, C. N. A. M., Damen, M. S. M. A., Cleophas, M. C. P., Netea, M. G., & van Crevel, R. (2015) · Journal of Diabetes Research · doi:10.1155/2016/6014631 · Cited by 110
“In particular we investigated the effects of varying doses of acetate (C2), propionate (C3), and butyrate (C4) on H37Rv-induced cytokine responses, with RPMI as negative 4 Journal of Diabetes Research control and LPS as positive control (Figure 1).”
BackgroundMethodCrittenden, S., Goepp, M., Pollock, J., Robb, C. T., Smyth, D. J., Zhou, Y., Andrews, R., Tyrrell, V. J., Gkikas, K., Adima, A., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd7954 · Cited by 104
High animal protein diet and gut microbiota in human health
Cai, J., Chen, Z., Wu, W., Lin, Q., & Liang, Y. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1898336 · Cited by 107
Featured article: Structure moderation of gut microbiota in liraglutide-treated diabetic male rats
Zhang, Q., Xiao, X., Zheng, J., Li, M., Yu, M., Ping, F., Wang, T., & Wang, X. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370217743765 · Cited by 101
“There was an increase in Prevotella in abundance in patients with T2D comparing with the healthy control group.(19) Another group showed increased Prevotella genus in abundance in patients with glucose intolerance.”
Probiotics for preventing gestational diabetes
Barrett, H. L., Dekker Nitert, M., Conwell, L. S., & Callaway, L. K. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009951.pub2 · Cited by 101
Metagenomics: Key to Human Gut Microbiota
Maccaferri, S., Biagi, E., & Brigidi, P. (2011) · Digestive Diseases · doi:10.1159/000332966 · Cited by 122
Management of metabolic syndrome through probiotic and prebiotic interventions
Grover, S., Mallappa, R., Rokana, N., Duary, R., Panwar, H., & Batish, V. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.91178 · Cited by 95
Shamasbi, S. G., Dehghan, P., Mohammad‐Alizadeh‐Charandabi, S., Aliasgarzadeh, A., & Mirghafourvand, M. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1648-7 · Cited by 105
Li, B., Evivie, S. E., Lu, J., Jiao, Y., Wang, C., Li, Z., Liu, F., & Huo, G. (2018) · Food & Function · doi:10.1039/c8fo01768a · Cited by 99
Guo, H., Wu, H., & Li, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24086978 · Cited by 123
D-Lactate: Implications for Gastrointestinal Diseases
Remund, B., Yılmaz, B., & Sokollik, C. (2023) · Children · doi:10.3390/children10060945 · Cited by 121
“However, patients with DM can show a dysbiosis [87,88] and an impaired intestinal barrier [89].”
BackgroundContribution of the Intestinal Microbiota to Human Health: From Birth to 100 Years of Age
Cheng, J., Palva, A., de Vos, W. M., & Satokari, R. M. (2011) · Current topics in microbiology and immunology · doi:10.1007/82_2011_189 · Cited by 109
“The enrichment of Actinobacteria was not significantly different between groups (Larsen et al. 2010).”
BackgroundCarrothers, J. M., York, M. A., Brooker, S. L., Lackey, K. A., Williams, J. E., Shafii, B., Price, W. J., Settles, M. L., McGuire, M. A., & McGuire, M. K. (2015) · Journal of Nutrition · doi:10.3945/jn.115.211110 · Cited by 110
Metadata
- Authors
- Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Corresponding author
- Larsen, Nadja
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-02-05
- Volume
- 5
- Issue
- 2
- Pages
- e9085
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2816710
- OpenAlex
- W2135989088
- Cited by
- 2,952
- References
- 38
- Citations by year
- 2026: 90 · 2025: 168 · 2024: 217 · 2023: 199 · 2022: 296 · 2021: 331 · 2020: 294 · 2019: 264 · 2018: 191 · 2017: 158 · 2016: 174 · 2015: 150 · 2014: 134 · 2013: 115 · 2012: 83
- FWCI
- 36.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Ministeriet for Fø devarer, Landbrug og Fiskeri
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- type 2 diabetes, gut microbiota, Firmicutes, Bacteroidetes, Betaproteobacteria, plasma glucose, glucose tolerance, obesity, metabolic disorders, 16S rRNA gene
- MeSH terms
- Adult, Aged, Bacteria, Diabetes Mellitus, Type 2, DNA, Bacterial, Feces, Humans, Intestines, Male, Middle Aged, RNA, Ribosomal, 16S, Colony Count, Microbial, Body Mass Index, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.